Relative Risk of Major Risk of Chronic Major Disease Catego ries, by Gender and Gender and verag e Drinkin e Dr g Catego Females Males Disease Disea

Similar documents
BEER AND CARDIOVASCULAR HEALTH: EFFECTS ON MORBIDITY AND MORTALITY. Simona Costanzo THE 7 TH EUROPEAN BEER AND HEALTH SYMPOSIUM

The burden caused by alcohol

Jürgen Rehm 1,2,3, Robert Mann 1,2 & Jayadeep Patra 1 1 Centre for Addiction and Mental Health, Toronto, Canada 2 Dalla Lana School of Public Health,

Dyslipidemia in women: Who should be treated and how?

Alcohol Consumption and Mortality Risks in the U.S. Brian Rostron, Ph.D. Savet Hong, MPH

I t is established that regular light to moderate drinking is

The Clinical Unmet need in the patient with Diabetes and ACS

A nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD

Alcohol and Cancer: Defining the Exposure and Key Milestones in Establishing the Relationship

Supplement materials:

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures

The burden of death, disease and disability due to alcohol in New Zealand

Diabetes Mellitus: A Cardiovascular Disease

Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial

Fasting or non fasting?

Barnyard Brouhaha: What About Dairy and Eggs in the Diet? Edwin Cox, M.D. OLLI

Overview of effects of alcohol intake on cardiovascular disease

The TNT Trial Is It Time to Shift Our Goals in Clinical

ORIGINAL INVESTIGATION. Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Wine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction

Melanie Nichols, 1,2 Peter Scarborough, 2 Steven Allender, 1,2 Mike Rayner 2

Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

Statins for Cardiovascular Disease Prevention in Women: Review of the Evidence

Is Lower Better for LDL or is there a Sweet Spot

CVD risk assessment using risk scores in primary and secondary prevention

Preventive Cardiology Scientific evidence

Alcohol and cancer. Peter Anderson MD, MPH, PhD

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Glycemic control a matter of life and death

Misperceptions still exist that cardiovascular disease is not a real problem for women.

Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

Managing HTN in the Elderly: How Low to Go

Antihypertensive Trial Design ALLHAT

Controversies in Preventative Cardiology

J. Michael Gaziano, M.D., M.P.H. European Society of Cardiology August 26 th 2018

Nutraceuticals and Cardiovascular Disease: Are we fishing?

New Antihypertensive Strategies to Improve Blood Pressure Control

Modifiable Up-Stream Risk Factors:

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Methods. OR and PAR both presented with 99% confidence intervals. All analyses adjusted for age, sex and region.

Table Cohort studies of consumption of alcoholic beverages and cancers of the lymphatic and haematopoietic system in the general population

Timing of angiography for high- risk ACS

7 th Munich Vascular Conference

I t is well established that non-insulin dependent diabetes is

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Blood Pressure Treatment Goals

Blood Pressure Targets: Where are We Now?

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU

Alcohol (Minimum Pricing) (Scotland) Bill. Chest Heart & Stroke Scotland

Figure 1 Modelling of diseases in PRIMEtime (after Barendregt et al. [7])

Supplementary Appendix

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

STATIN THERAPY IN THE ELDERLY: THERE ARE MILES TO GO BEFORE WE SLEEP

Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease

The earlier BP control the better cardiovascular outcome. Jin Oh Na Cardiovascular center Korea University Medical College

Role of alcohol in the Eastern European mortality crisis

T. Suithichaiyakul Cardiomed Chula

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

Blood Pressure Targets in Diabetes

New York Cardiovascular Symposium New York, December New York Hilton Midtown

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center

The University of Mississippi School of Pharmacy

American Academy of Insurance Medicine

Rikshospitalet, University of Oslo

Macrovascular Disease in Diabetes

HORMONE REPLACEMENT THERAPY

Alcohol and the heart: to abstain or not to abstain?

Supplementary webappendix

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Heart Disease Genesis

Sugar consumption and health: an update of the evidence

NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N

Folate, vitamin B 6, and vitamin B 12 are cofactors in

Welcome! Mark May 14, Sat!

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode Island Cardiology Center

Weigh the benefit of statin treatment: LDL & Beyond

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

Dabigatran Evidence in Real Practice

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Mortality in relation to alcohol consumption: a prospective study among male British doctors

The relationships between alcohol, wine and cardiovascular diseases Areview

Barnyard Brouhaha: What About Dairy and Eggs in the Diet? Edwin Cox, M.D. OLLI

Complications of Diabetes: Screening and Prevention

Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats

Decline in CV-Mortality

Antithrombotic therapy in the ACS patient with atrial fibrillation

Effects of alcohol consumption on mortality in patients with Type 2 diabetes mellitus

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study. Results at 1 Year

Is there a mechanism of interaction between hypertension and dyslipidaemia?

Lipid Management 2013 Statin Benefit Groups

Coronary Heart Disease in Women Go Red for Women

Transcription:

38 th IMAG Conference, Amsterdam, October 13-14, 14, 2014 International Meeting on Alcohol and Global Health Overview: All-Cause Mortality Wolfgang Koenig MD, FRCP, FESC, FACC, FAHA Dept. of Internal Medicine II - Cardiology, University of Ulm Medical Center, Ulm, Germany

Alcohol Use and Your Health http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm

Kiechl et al. Circulation 2014;130:383-386386 Five-year Changes in Recorded per Capita Alcohol (15+ years) Consumption, 2006-20102010

Kiechl et al. Circulation 2014;130:383-386386 Alcohol-attributable Fractions for All-Cause Deaths, 2012

Relative Risk of Major Chronic Disease Categories, by Gender and Average Drinking Category Disease ICD-9 code ICD-10 code Malignant neoplasms 140-208 C00-C97C97 Mouth and oropharynx cancers I 0-20 Females II 20-40 Drinking Category III 40+ I 0-40 Males II 40-60 III 60+ 140-149149 C00-C14C14 1.45 1.85 5.39 1.45 1.85 5.39 Esophagus cancer 150 C15 1.80 2.38 4.36 1.80 2.38 4.36 Liver cancer 155 C22 1.45 3.03 3.60 1.45 3.03 3.60 Breast cancer 1.14 1.41 1.59 Under 45 years of age 174 C50 1.15 1.41 1.46 45 years and over 1.14 1.38 1.62 Other neoplasms 210-239239 D00-D48D48 1.10 1.30 1.70 1.10 1.30 1.70 Diabetes mellitus 250 E10-E14E14 0.92 0.87 1.13 1.00 0.57 0.73 Rehm et al. NIAAA: Understanding the impact of alcohol on human health and well-being, 2003

Relative Risk of Major Chronic Disease Categories, by Gender and Average Drinking Category Disease ICD-9 code ICD-10 code Digestive diseases 530-579579 K20-K92K92 I Females II Drinking Category Males III I II Cirrhosis of the liver 571 K70, K74 1.26 9.54 9.54 1.26 9.54 9.54 III Neuropsychiatric conditions Unipolar major depression 290-319, 324-359359 F01-F99, F99, G06-G98G98 300.4 F32-F33F33 RR not available; AF could not be determined otherwise (Rehm et al., in press b) Epilepsy 345 G40-G41G41 1.34 7.22 7.52 1.23 7.52 6.83 Alcohol use disorders 291, 303, 305.0 F10 AF 100% AF 100% AF 100% AF 100% AF 100% AF 100% Rehm et al. NIAAA: Understanding the impact of alcohol on human health and well-being, 2003

Relative Risk of Major Chronic Disease Categories, by Gender and Average Drinking Category Disease Females Drinking Category Males ICD-9 code ICD-10 code I II III I II III Cardiovascular 390-459 I00-I99I99 diseases (CVD) Hypertensive disease 401-405405 I10-I13I13 1.40 2.00 2.00 1.40 2.00 4.10 Coronary heart disease 410-414414 I20-I25I25 0.82 0.83 1.12 0.82 0.83 1.00 Cerebrovascular disease 430-438438 I60-I69I69 Ischemic stroke 0.52 0.64 1.06 0.94 1.33 1.65 Hemorrhagic stroke 0.59 0.65 7.98 1.27 2.19 2.38 Other CVD causes 415-417, 417, 423-424, 424, 426-429, 429, 440-448, 448, 451-459459 I00, I26- I28, I34- I37, I44- I51, I70- I99 1.50 2.20 2.20 1.50 2.20 2.20 Rehm et al. NIAAA 2003

*Oxid., FMD, Coag., LF and IS, the Heart and Fat Tissue Kiechl et al. Circulation 2014;130:383-386386 Proposed Mechanistic Insights into Protective* (green) as well as Injurious (red) Effects of Alcohol

Di Castelnuovo, A. et al. Arch Intern Med 2006;166:2437-24452445 Relative Risk of Total Mortality (95% CI) and Alcohol Intake: Meta-analysis analysis of 34 Prospective Studies Extracted from 56 Curves Using Fixed- and Random-effects Models 6g/d ~1/2 drink 42g/d ~ 4 drinks Max. reduction in women 18% (99%CI 13%-22%) in men 17% (99% CI 15%-19%)

Relative Risk of Total Mortality (99% CI) and Alcohol Intake: Meta-analysis analysis of 34 Prospective Studies in - men and women (A) - women (B) - men (C) in the - United States - Europe - other countries (Australia, Japan, and/or China), extracted from adjusted curves Di Castelnuovo, A. et al. Arch Intern Med 2006;166:2437-2445.

Ronksley et al. BMJ 2011;342:d671 (84 Studies) WHAT IS ALREADY KNOWN ON THIS TOPIC: Systemic reviews have addressed the association of alcohol consumption with various cardiovascular outcomes However, these reviews are somewhat out of date, and none has comprehensively studied a broad spectrum of relevant cardiovascular end points WHAT THIS STUDY ADDS This meta-analysis analysis provides a summary of current knowledge regarding alcohol associations with six meaningful clinical end points cardiovascular disease mortality, coronary heart disease and mortality, stroke incidence and mortality, and all cause mortality The results confirm the beneficial effects of moderate alcohol consumption and the need to elucidate the underlying pathophysiological mechanisms

Ronksley et al. BMJ 2011;342:d671 Forest Plot of Mortality from All Causes Associated with Alcohol Consumption (31 Studies) Lowest Relative Risk of 0.83 (0.80-0.86) for those consuming 2.5-14.9 g/day

Association of Alcohol Consumption With CV or Total Mortality in CVD Patients Study Country No. Sex Follow-up, y Primary Event Secondary Event Doll, 1994 18 UK 5402 Men 13.0 CVD+CV-RF Thun, 1997 19 USA 152240 Both 9.0 CVD+CV-RF Janszky, 2008 20 Sweden 1346 Both 8.6 AMI Masunaga, 2006 21 Japan 3845 Men 1.1 AMI Aguilar, 2004 22 USA 2036 Both 3.5 AMI Jackson, 2003 23 USA 1320 Men 4.5 Stroke Mukamal, 2001 25 USA 1913 Both 3.8 AMI Shaper, 2000 25 UK 596 Men 12.8 CHD Valmadrid, 1999 26 USA 262 Both 12.3 ACS Muntwyler, 1998 27 USA 5356 Men 5.0 AMI AC-M, CV-M AC-M, CV-M AC-M,CV-M, CV-M+CVD AC-M, CV-M+CVD AC-M, CV-M, CV-M+CVD AC-M, CV-M AC-M, CV-M AC-M, CV-M CV-M AC-M, CV-M UK indicates United Kingdom; CV-RF, cardiovascular risk factors; AC-M, all-cause mortality; CV-M, cardiovascular mortality; USA, United States of America; and ACS, acute coronary syndrome. Funded by ERAB Costanzo et al. Circulation 2010;121:1951-19591959

Relative Risk of Cardiovascular Mortality Relative Risks of Cardiovascular Mortality with 1.4 Different Intakes of Alcohol in CVD Patients 1.2 1 0.8 0.6 0.4 0.2 0 5 Funded by ERAB 10 15 20 25 30 35 40 Alcohol Consumption (grams/day) Janszky, 2008 Aguilar, 2006 Jackson, 2003 Mukamal, 2001 Shaper, 2000 Valmadrid, 1999 Muntwyler, 1998 Costanzo et al. Circulation 2010;121:1951-19591959

Relative Risk of All-Cause Mortality Relative Risks of Total Mortality with Different 1.4 Intakes of Alcohol in Studies of CVD Patients 1.2 1 0.8 0.6 0.4 0.2 0 5 10 15 20 25 30 35 40 Funded by ERAB Alcohol Consumption (grams/day) Janszky, 2008 Masunaga, 2006 (age <65yr) Masunaga, 2006 (age 65yr) Aguilar, 2006 Jackson, 2003 Mukamal, 2001 Shaper, 2000 Muntwyler, 1998 (age <65yr) Muntwyler, 1998 (age 65yr) Costanzo et al. Circulation 2010;121:1951-19591959

Mukamal et al. JAMA 2001;285:1965-19701970 Survival Following Acute Myocardial Infarction (AMI) According to Average Alcohol Consumption

Mukamal et al. JAMA 2001;285:1965-19701970 Hazard Ratios for Mortality Following Acute Myocardial Infarction According to Alcohol Consumption

Mukamal et al. JAMA 2001;285:1965-19701970 Hazard Ratios for All-Cause Mortality According to Alcohol Consumption by Predominant Beverage Type*

Pai et al. Eur Heart J 2012;33:1598-16051605

Pai et al. Eur Heart J 2012;33:1598-16051605 Baseline Lifestyle and Clinical Characteristics of 1818 Men with Incident Non-Fatal MI in the HPFU Study

Pai et al. Eur Heart J 2012;33:1598-16051605 Long-term Alcohol Intake and Risks for Total Death and CVD Death Among 1818 Men with Incident Non-Fatal MI

Pai et al. Eur Heart J 2012;33:1598-16051605 Beverage-specific Long-term Alcohol Consumption and Risks of Total Death Among 1818 Men with Incident Non-Fatal MI

Zaridze et al. Lancet 2014;383:1465-14731473 All-Cause Mortality, Males Aged 15-5454 Years, in Russia From 1980-2012 and in the UK From 1980-2010

Alcohol and Cardiovascular Mortality Common Sense and Scientific Truth*...The risks of moderate drinking differ by sex, age, personal history, and family history. As is often the case in medical practice, advice about life-style must be based on something less than certainty. There is no substitute for balanced judgement by a knowledgeable, objective health professional. What is required is a synthesis of common sense and the best available scientific facts. *Editorial by A.L. Klatsky JACC 2010;55:1336-13391339

Department of Cardiology University of Ulm Medical Center The New York Times, Sunday May 8, 2005 University of Ulm Medical Center

Alcohol Consumption in Relation to MI Diagnosis Pai et al. Eur Heart J 2012;33:1598-16051605

Kaplan-Meier Estimates of Survival After Acute MI Among Binge Drinkers and Nonbinge Drinkers* *matched by Propensity Score Mukamal et al. Circulation 2005;112:3839-38453845

Mukamal et al. Circulation 2005;112:3839-38453845 Adjusted HRs for Mortality After Acute MI According to Binge Drinking and Usual Alcohol Intake

Mukamal et al. Circulation 2005;112:3839-38453845 HRs and 95% CIs for All-Cause, Cardiovascular, and Noncardiovascular Mortality After Acute MI According to Drinking Among Onset Study Participants

Mukamal et al. Circulation 2005;112:3839-38453845 Additional Adjusted Analyses of Binge Drinking and Total Mortality Among Onset Study Participants

Pai et al. Eur Heart J 2012;33:1598-16051605 Change in Alcohol Consumption Pattern and Risks for Total Death and Death due to CVD Among the 1633 Men who Reported Alcohol Consumption on the Questionnaires Immediately Before and After MI Diagnosis